Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

3 Quotes From PayPal's Q1 Earnings That Show Its Pandemic Boost Is Sticking
3 Quotes From PayPal's Q1 Earnings That Show Its Pandemic Boost Is Sticking

PayPal Holdings (NASDAQ: PYPL) is off to a great start in 2021. The digital payments provider processed $285 billion worth of transactions in the first quarter alone. It was the company's strongest

SolarEdge Technologies: Buy the Dip?
SolarEdge Technologies: Buy the Dip?

SolarEdge Technologies (NASDAQ: SEDG) stock fell nearly 16% after it reported its first-quarter results. The stock is nearly 40% off its high this year. Renewable energy stocks, including solar, are

Why Freshpet's CEO Believes Revenue Run Rate Could Hit $1 Billion in 2022Photo, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Why Freshpet's CEO Believes Revenue Run Rate Could Hit $1 Billion in 2022

Pet food is a boring, sluggish industry with growth rates historically under 5%. Freshpet (NASDAQ: FRPT) is an anomaly in that its refrigerated dog and cat food is growing fast and taking market

Should You Buy Trupanion in May?Photo, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Should You Buy Trupanion in May?

Shares of pet insurance pioneer, Trupanion (NASDAQ: TRUP) soared in 2020 along with new pet adoptions. A net loss that was larger than expected, though, has kept the stock depressed since the

Air Force Skyborg AI Takes Flight With a Kratos DronePhoto, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
Air Force Skyborg AI Takes Flight With a Kratos Drone

Skyborg, an experimental Air Force system designed to use artificial intelligence (AI) to guide autonomous drones in battle situations, has taken flight for the first time.

We're still a long way

Corsair Gaming Just Became a Screaming Buy
Corsair Gaming Just Became a Screaming Buy

Any doubts about Corsair Gaming (NASDAQ: CRSR) sustaining its growth after the massive lockdown-fueled gains it recorded last year were largely put to rest when it released its first-quarter

3 Reasons to Be Excited About Activision Blizzard After Its Q1 Results
3 Reasons to Be Excited About Activision Blizzard After Its Q1 Results

Activision Blizzard (NASDAQ: ATVI) released its first-quarter results on May 4. The company beat analysts' expectations on the top and bottom lines with sales of $2.28 billion and earnings per share

You'll Definitely Regret Delaying Social Security Until 70 If This Happens
You'll Definitely Regret Delaying Social Security Until 70 If This Happens

Delaying your claim for Social Security until the age of 70 is often the right financial move. Many financial experts agree it makes sense to wait to get benefits because delaying maximizes monthly

Is Etsy Still Unstoppable After a Major Sell-Off?
Is Etsy Still Unstoppable After a Major Sell-Off?

Etsy (NASDAQ: ETSY), the online marketplace that specializes in handmade and vintage goods, disappointed investors when it announced first-quarter results on May 5.

Although revenue and net income

Moderna's Vaccine Produces Antibodies for at Least 6 Months
Moderna's Vaccine Produces Antibodies for at Least 6 Months

Moderna (NASDAQ: MRNA) reported data showing participants in its coronavirus vaccine trial continued to have antibodies to the virus six months later. In this video from Motley Fool Live, recorded

3 Stocks That Are Absurdly Cheap Right Now
3 Stocks That Are Absurdly Cheap Right Now

With many financial headlines describing "frothy" markets at or near "all-time highs," investors may think most stocks are extremely expensive. But in every market, there's usually something out

3 Steps to Making Millions in the Stock Market
3 Steps to Making Millions in the Stock Market

A lot of people regard the stock market as a scary, unpredictable thing, but actually, stocks have a long history of delivering solid returns. As such, investing in stocks is a good way to turn

3 ETFs That Can Make You Rich
3 ETFs That Can Make You Rich

For more than a year, volatility has been a way of life for investors. The uncertainty brought about by the coronavirus pandemic ultimately sent the CBOE Volatility Index, which measures the

3 Cathie Wood Stocks That Could Deliver Bigger Gains Than Dogecoin
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than Dogecoin

Brace yourself for an even greater buzz for Dogecoin (CRYPTO: DOGE) after Elon Musk hosted Saturday Night Live over the weekend. Musk is one of the most visible -- and vocal -- fans of the

3 Robinhood Stocks With High Dividend Yields
3 Robinhood Stocks With High Dividend Yields

You'll find quite a bit of variety when you look at the 100 most popular stocks on Robinhood. There are several meme stocks. Plenty of pot stocks. A boatload of tech stocks. And, yes, Robinhood

5 Growth Stocks Rocketing Up My Prospective Buy List
5 Growth Stocks Rocketing Up My Prospective Buy List

Approximately 13.5 months ago, uncertainty on Wall Street hit its peak and the benchmark S&P 500 bottomed out. Since hitting its trough on March 23, 2020, it's returned as much as 88%, not including

3 Ways Your Employer Could Mess Up Your 401(k)
3 Ways Your Employer Could Mess Up Your 401(k)

Saving for retirement in a 401(k) is kind of like hiring a contractor to build your house. You define the scope of the project, provide the financing, and ultimately get to enjoy the end result, but

Sorry to Say: You Probably Shouldn't Claim Social Security at 62
Sorry to Say: You Probably Shouldn't Claim Social Security at 62

You have choices when it comes to signing up for Social Security. Many seniors opt to claim their benefits at full retirement age, or FRA. That age is either 66, 67, or somewhere in between

Why MakeMyTrip Stock Fell 13.2% Last Month
Why MakeMyTrip Stock Fell 13.2% Last Month

Shares of MakeMyTrip (NASDAQ: MMYT) dipped 13.2% in April, according to data from S&P Global Market Intelligence. India faced surging COVID-19 infections and deaths, and it's not surprising that the

Got $5,000? 2 Tech Stocks to Buy and Hold For the Long Term
Got $5,000? 2 Tech Stocks to Buy and Hold For the Long Term

Many investors look at Amazon and wish they had bought its stock when the company sold only books. And they will often set their sights on finding the "next Amazon."

While finding superstars at an

Is Generic-Drug Maker Viatris a Keeper?
Is Generic-Drug Maker Viatris a Keeper?

In this video from Motley Fool Live, recorded on April 5, Fool.com Contributors Brian Orelli and Keith Speights discuss a question from a member named Angel, who asks whether Viatris (NASDAQ: VTRS)

Clearance? Approval? What Should Investors Make of Nano-X's FDA Decision?Photo, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Clearance? Approval? What Should Investors Make of Nano-X's FDA Decision?

Last month, Nano-X Imaging (NASDAQ: NNOX) gained 501(k) clearance from the Food and Drug Administration (FDA) for its X-ray device. In this video from Motley Fool Live, recorded on April 5, Fool.com

Why Shares of Chart Industries Climbed 13% in April
Why Shares of Chart Industries Climbed 13% in April

Falling more than 9% through the first three weeks of April, shares of Chart Industries (NYSE: GTLS) weren't giving investors much to celebrate -- especially since the S&P 500 had risen more than 4%

Some Prominent Doctors Continue to Shun Biogen's Alzheimer's DrugPhoto, wide shot, wide-angle lens,  Personal care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/44547be2-b411-43fb-91ed-bf4a69577d94.png
Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug

Biogen (NASDAQ: BIIB) will get a decision on Alzheimer's disease drug aducanumab next month, but a recent op-ed by members of the Food and Drug Administration (FDA) advisory committee that reviewed

Is Vaccine Maker Vaxart Worth Holding From Here?
Is Vaccine Maker Vaxart Worth Holding From Here?

Shares of vaccine expert Vaxart (NASDAQ: VXRT) have gone on a wild ride over the past 12 months as the company has released data for its coronavirus vaccine. In this video from Motley Fool Live